Increased Bioavailability of Cyclic Guanylate Monophosphate Prevents Retinal Ganglion Cell Degeneration

The nitric oxide – guanylyl cyclase-1 – cyclic guanylate monophosphate (NO-GC-1–cGMP) pathway has emerged as a potential pathogenic mechanism for glaucoma, a common intraocular pressure (IOP)-related optic neuropathy characterized by the degeneration of retinal ganglion cells (RGCs) and their axons...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurobiol Dis
Main Authors: Wareham, Lauren K., Dordea, Ana C., Schleifer, Grigorij, Yao, Vincent, Batten, Annabelle, Fei, Fei, Mertz, Joseph, Gregory-Ksander, Meredith, Pasquale, Louis R., Sappington, Rebecca M., Buys, Emmanuel S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6424569/
https://ncbi.nlm.nih.gov/pubmed/30213732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2018.09.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados